Evidence map›Paper›PMID 29144511›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2018

Evaluating CHARGE syndrome in congenital hypogonadotropic hypogonadism patients harboring CHD7 variants.

Cheng Xu, Daniele Cassatella, Almer M van der Sloot, Richard Quinton, Michael Hauschild, Christian De Geyter, Christa Flück, Katrin Feller, Deborah Bartholdi, Attila Nemeth and 11 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. DigenicHeliyon · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Expanding the reproductive organ phenotype of CHD7-spectrum disorder.American journal of medical genetics. Part A · 2023
    Article
  11. Article
  12. Advances in Genetic Diagnosis of Kallmann Syndrome and Genetic Interruption.Reproductive sciences (Thousand Oaks, Calif.) · 2022
    Review
  13. CHD7 in oocytes is essential for female fertility.Annals of translational medicine · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Classification ofFrontiers in genetics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 8 countries.

Cheng XuEndocrinology, Diabetology & Metabolism Service, Lausanne University Hospital, Lausanne, Switzerland.
Daniele CassatellaEndocrinology, Diabetology & Metabolism Service, Lausanne University Hospital, Lausanne, Switzerland.
Almer M van der SlootInstitute for Research in Immunology and Cancer, University of Montreal, Montreal, Canada.
Richard QuintonInstitute for Genetic Medicine, University of Newcastle-on-Tyne, Newcastle-on Tyne, UK.
Michael HauschildEndocrinology-Diabetology Unit, Department of Paediatrics, Lausanne University Hospital, Lausanne, Switzerland.
Christian De GeyterClinic of Gynecological Endocrinology and Reproductive Medicine, University Hospital, University of Basel, Basel, Switzerland.
Christa FlückDivision of Pediatric Endocrinology and Diabetology, Department of Pediatrics, and Department of Clinical Research, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Katrin FellerDivision of Endocrinology, Diabetes, and Clinical Nutrition, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
Deborah BartholdiDepartment of Human Genetics, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
Attila NemethDepartment of Endocrinology, St John's Hospital, Budapest, Hungary.
Irene HalperinDepartment of Endocrinology, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Sandra Pekic DjurdjevicClinic of Endocrinology, Diabetes, and Diseases of Metabolism, University Clinical Center, Belgrade, Serbia.
Philippe MaederDepartment of Radiology, Lausanne University Hospital, Lausanne, Switzerland.
Georgios PapadakisEndocrinology, Diabetology & Metabolism Service, Lausanne University Hospital, Lausanne, Switzerland.
Andrew A DwyerEndocrinology, Diabetology & Metabolism Service, Lausanne University Hospital, Lausanne, Switzerland.
Laura MarinoEndocrinology, Diabetology & Metabolism Service, Lausanne University Hospital, Lausanne, Switzerland.
Lucie FavreEndocrinology, Diabetology & Metabolism Service, Lausanne University Hospital, Lausanne, Switzerland.
Duarte PignatelliDepartment of Endocrinology, Hospital S João, Porto, Portugal.
Nicolas J NiederländerEndocrinology, Diabetology & Metabolism Service, Lausanne University Hospital, Lausanne, Switzerland.
James AciernoEndocrinology, Diabetology & Metabolism Service, Lausanne University Hospital, Lausanne, Switzerland.
Nelly PitteloudEndocrinology, Diabetology & Metabolism Service, Lausanne University Hospital, Lausanne, Switzerland. nelly.pitteloud@chuv.ch.
University of Lausanne · CHUniversity of Bern · CHInstitute for Research in Immunology and Cancer · CANewcastle University · GBSt. John's Hospital · USUniversidade do Porto · PTUniversitat de Barcelona · ESUniversity Hospital of Lausanne · CHUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCongenital hypogonadotropic hypogonadism (CHH), a rare genetic disease caused by gonadotropin-releasing hormone deficiency, can also be part of complex syndromes (e.g., CHARGE syndrome). CHD7 mutations were reported in 60% of patients with CHARGE syndrome, and in 6% of CHH patients. However, the definition of CHD7 mutations was variable, and the associated CHARGE signs in CHH were not systematically examined.

methodsRare sequencing variants (RSVs) in CHD7 were identified through exome sequencing in 116 CHH probands, and were interpreted according to American College of Medical Genetics and Genomics guidelines. Detailed phenotyping was performed in CHH probands who were positive for CHD7 RSVs, and genotype-phenotype correlations were evaluated.

resultsOf the CHH probands, 16% (18/116) were found to harbor heterozygous CHD7 RSVs, and detailed phenotyping was performed in 17 of them. Of CHH patients with pathogenic or likely pathogenic CHD7 variants, 80% (4/5) were found to exhibit multiple CHARGE features, and 3 of these patients were reclassified as having CHARGE syndrome. In contrast, only 8% (1/12) of CHH patients with nonpathogenic CHD7 variants exhibited multiple CHARGE features (P = 0.01).

conclusionPathogenic or likely pathogenic CHD7 variants rarely cause isolated CHH. Therefore a detailed clinical investigation is indicated to clarify the diagnosis (CHH versus CHARGE) and to optimize clinical management.

Indexed as

CHARGE SyndromeDNA-Binding ProteinsDNA HelicasesFamilyFemaleGenetic Association StudiesGenetic VariationHeterozygoteHumansHypogonadismMaleMutationPedigreePhenotypeSequence Analysis, DNACHD7 protein, humanDNA-Binding ProteinsDNA HelicasesCHARGE syndromechromodomain helicase DNA binding protein 7congenital hypogonadotropic hypogonadismKallmann syndrome

Identifiers

PMID29144511
OpenAlexW2770361158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.